H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Teva Pharmaceuticals USA, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Teva Pharmaceuticals USA, Inc.
NJRank #FEIN 22-1734359

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPTeva Pharmaceuticals USA, Inc.
Total filings80,813341
Certified %98.23%80.06%
Denied %1.09%0.88%
Withdrawn %0.61%6.16%
Cert-withdrawn %0.07%12.90%
Rank#4
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePANJ

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Teva Pharmaceuticals USA, Inc.

DOL case-status mix.

Outcome breakdown: Certified 80.1%, Cert-withdrawn 12.9%, Withdrawn 6.2%, Denied 0.9%
Outcome breakdown
OutcomeShare
Certified80.1%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%
Certified80.1%
Cert-withdrawn12.9%
Withdrawn6.2%
Denied0.9%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Teva Pharmaceuticals USA, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY201010
FY201110
FY201228
FY201311
FY201417
FY201534
FY201630
FY201751
FY201865
FY201940
FY20205
FY202113
FY20228
FY20232
FY20244
FY20257
FY20266

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Teva Pharmaceuticals USA, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.